Press

 

A core objective of BRIGHT is to share our results, progress, and to increase the knowledge about Bilharzia.

 

To see the latest news about BRIGHT: News section

 

Do you want to know what we are doing?

Follow us on Twitter.

 

A collection of high resolution downloadable photographs of the people of BRIGHT and our work can be found in our photo gallery. Although the situations portrayed on this website are typical of the research none of the persons in this website are research patients (study participants). None of the persons portrayed in the treatment and investigative situations are minors. They have kindly given their permissions to publish the images. Please credit photographer Håvard Holme if you want to use any of the pictures.

 

For more questions please contact our communication officer:

Ida Amelie Helgesen

[email protected]

South Africa no: (+27) 76 692 819

Norwegian n0: (+47) 906 56 702


Follow on social media


PhD in Female Genital Schistosomias

The examiners of Dr Pavitra Pillay’s PhD thesis wrote: “I am highly impressed with the excellent quality…. this work is of vital importance for South Africa and should be heard by anybody interested cervical cancer”.  “The studies have been well planned and the candidate has done very nice and solid scientific work.” In her thesis Dr Pillay has shown how schistosomiasis can be a potential risk factor for the acquisition cervical squamous cell atypia and HIV. It is recommended that regular mass drug administration for schistosomiasis is implemented and public health interventions raising awareness of cervical cancer are instituted targeting young women and men in endemic populations. Title: “Female genital schistosomiasis (FGS) is a potential risk factor for squamous cell atypia and HIV among young women from schistosomiasis endemic populations” PhD registered: University of KwaZulu-Natal (UKZN), South Africa Main supervisor: Professor Myra Taylor, UKZN Co-supervisors: Dr Eyrun F Kjetland, Oslo University Hospital, Norway/UKZN and Professor Lisette van Lieshout, Leiden University Medical Centre, The Netherlands Other supervisor: Professor Borghild Roald, University of Oslo, Norway  ... read more

Soil Transmitted Helminths (STHs) to be treated in National School Deworming Programme

South African Broadcasting Corporation:  The Departments of Basic Education, Health and Social Development have today officially launched the national school de-worming programme [for STHs with Mebendazole] at the Zimasa Primary school in Langa. The programme forms part of the integrated school health programme and will focus on health, education and the regular de-worming of children. The programme will be rolled out nationally to all Grade R to 7 learners in quintile one to three primary schools. The Department of Basic Education has partnered with the World Health Organisation and has secured seven million de-worming tablets that will be distributed to the children. Basic Education minister Angie Motshekga, says the schools chosen are all part of the departments pro-poor programme. Motshekga was joined by various stake-holders on a walkabout to the nurses’ rooms where the de-worming tablets and other  vaccines will be administered.   Five hard facts: Soil transmitted helminths (STHs) in South Africa constitute the worms A. lumbrocoides, T. trichiura, and hookworm. They cause tiredness and stomach problems. Further, these worms and have been found to contribute to cycle of poverty. Repeated treatment is necessary to curb the reinfections The school deworming programme will not treat Bilharzia which is the second most important parasite after Malaria in terms of public health impact in the world. Quintile 1-3 (of five in total) are the poorest schools in South Africa. These schools also have a school feeding programme. Mebendazole is the only the second best choice treatment for these STHs. For T. trichiura Albendazole should be given.   Literature Berge ST, Kabatereine NB, Gundersen SG, et al.; Generic praziquantel in South Africa: The necessity for policy change to avail cheap, safe... read more

Last Sunday of January is World Leprosy day

The Leprosy Mission’s Dr Laubscher shared the following message from leprosy patients: They are keen to speak about the disease and address issues of stigma They don’t want other cases to wait for decades for treatment They want to be part of health education They are convinced that there are many undiagnosed cases They don’t want their families to suffer They want to be heard by the Department of Health Their independence is important to them They are interested in economic development of people with disabilities For more information contact Dr Laubscher... read more
(Page 5 of 10)« First...34567...10...Last »